Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09FGX
|
||||
Former ID |
DNC009018
|
||||
Drug Name |
ELACRIDAR
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Discontinued in Phase 1 | [545232] | ||
Structure |
Download2D MOL |
||||
Formula |
C34H34ClN3O5
|
||||
Canonical SMILES |
COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5<br />CCC6=CC(=C(C=C6C5)OC)OC
|
||||
InChI |
1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)
|
||||
InChIKey |
OSFCMRGOZNQUSW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Multidrug resistance protein 1 | Target Info | Inhibitor | [529846] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.